{"id":24003,"date":"2017-02-24T12:51:17","date_gmt":"2017-02-24T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=24003"},"modified":"2018-04-14T02:15:33","modified_gmt":"2018-04-14T07:15:33","slug":"24003","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/24003\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 24 de fevereiro de 2017"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_2-24-17.pdf\">compat\u00edvel com impressora<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <br \/>\nNot\u00edcias e notas sobre sa\u00fade animal de 24 de fevereiro de 2017<\/strong><br \/>\nCopyright \u00a9 Brakke Consulting, Inc.<br \/>\n&nbsp;<br \/>\nEditor: Lynn Fondon DVM MBA<br \/>\n************************************<br \/>\nNAS NOTICIAS:<br \/>\n&nbsp;<br \/>\n<u>Novidades da Brakke Consulting<\/u><br \/>\nVis\u00e3o geral da ind\u00fastria na WVC<br \/>\nCanal OTC <br \/>\n&nbsp;<br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de ganhos<\/u><br \/>\nAvivagen <br \/>\nBayer<br \/>\nGrupo Eb\u00f3s<br \/>\nHenry Schein <br \/>\nJM Smucker <br \/>\nPatterson<br \/>\n&nbsp;<br \/>\n<u>outras not\u00edcias<\/u><br \/>\nAnzac Sa\u00fade Animal<br \/>\nProdutos para animais de estima\u00e7\u00e3o BuddyRest <br \/>\nCeva (Cevac IBron)<br \/>\nCeva (EBVAC)<br \/>\nCipla Vet <br \/>\nEBVAC <br \/>\nVisualize<br \/>\nFolhas de bordo <br \/>\nVetStem Biopharma<br \/>\nZoetis (Diroban)<br \/>\nZoetis (Citoponto)<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n<strong>BRAKKE CONSULTING, INC.<br \/>\nVIS\u00c3O GERAL DA IND\u00daSTRIA DE 2017 <br \/>\nINSCRI\u00c7\u00c3O PARA VIS\u00c3O GERAL NO WVC <br \/>\nINSCRI\u00c7\u00d5ES ON-LINE TERMINAM SEXTA-FEIRA!<\/strong><\/p>\n<p>A Brakke Consulting tem o prazer de anunciar a Vis\u00e3o Geral da Ind\u00fastria de 2017. A Vis\u00e3o Geral da Ind\u00fastria de Sa\u00fade Animal dos EUA de 2017 ser\u00e1 apresentada na Western Veterinary Conference em Las Vegas, Nevada:<\/p>\n<p>\u2022 WVC: ter\u00e7a-feira, 7 de mar\u00e7o de 2017, das 14h \u00e0s 16h, Four Seasons.<\/p>\n<p>Para se inscrever, acesse <a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> e role para baixo at\u00e9 a \u00e1rea \u201cnovidades\u201d da p\u00e1gina inicial. As inscri\u00e7\u00f5es online terminam na sexta-feira, 3 de mar\u00e7o; ap\u00f3s esse hor\u00e1rio, registre-se no local.<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<\/p>\n<p>***********************************<br \/>\nRELEASES DE RESULTADOS DA EMPRESA<\/p>\n<p>\u2022 A Bayer divulgou os resultados para o ano completo de 2016. As vendas do neg\u00f3cio de Sa\u00fade Animal foram de 1,52 bilh\u00e3o de euros ($1,60 bilh\u00e3o), um aumento de 2% (+5% com ajuste de moeda e portf\u00f3lio). (site da companhia)<\/p>\n<p>\u2022 A Henry Schein reportou os resultados financeiros do ano de 2016. As vendas de Sa\u00fade Animal foram de $3,25 bilh\u00f5es, um aumento de 11% em compara\u00e7\u00e3o com 2015. As vendas de Sa\u00fade Animal na Am\u00e9rica do Norte foram de $1,68 bilh\u00f5es, um aumento de 16% em compara\u00e7\u00e3o com o ano anterior. (comunicado de imprensa da empresa)<\/p>\n<p>\u2022 Os resultados da Patterson Companies, Inc. para seu terceiro trimestre fiscal encerrado em 28 de janeiro de 2017. As vendas l\u00edquidas reportadas da Patterson Animal Health foram de $763 milh\u00f5es, um aumento de 2% em rela\u00e7\u00e3o ao per\u00edodo compar\u00e1vel do ano passado (+5% por cento em uma base de moeda constante). (site da companhia)<\/p>\n<p>\u2022 A JM Smucker Company anunciou os resultados do terceiro trimestre do ano fiscal de 2017 encerrado em 31 de janeiro de 2017. As vendas do segmento Pet Foods foram de $551 milh\u00f5es, um decl\u00ednio de 4% em compara\u00e7\u00e3o com o trimestre compar\u00e1vel do ano anterior. O lucro do segmento aumentou 2% para $126 milh\u00f5es. (site da companhia)<\/p>\n<p>\u2022 O Grupo Ebos divulgou resultados para os seis meses encerrados em 31 de dezembro de 2016. A receita de cuidados com animais aumentou 6% por cento, para NZ$216 milh\u00f5es (US$150 milh\u00f5es); os ganhos aumentaram 11% para NZ$21,1 milh\u00f5es ($14,7 milh\u00f5es). Ebos possui v\u00e1rias empresas de sa\u00fade animal e animais de estima\u00e7\u00e3o com sede na Austr\u00e1lia e na Nova Zel\u00e2ndia. (Business.scoop.co.nz)<\/p>\n<p>\u2022 A Avivagen Inc. anunciou seus resultados para o primeiro trimestre encerrado em 31 de janeiro de 2017. A receita total do trimestre foi de $62.337. A perda do primeiro trimestre foi de $(1) milh\u00f5es. A Avivagen tinha caixa e equivalentes de caixa de $5,5 milh\u00f5es em 31 de janeiro de 2017. (comunicado \u00e0 imprensa da empresa)<br \/>\n&nbsp;<br \/>\n&nbsp;<br \/>\n**********************************<br \/>\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/p>\n<p>\u2022 A FDA anunciou a aprova\u00e7\u00e3o do Diroban (dicloridrato de melarsomina), o primeiro medicamento gen\u00e9rico para tratar dirofilariose em c\u00e3es. O pedido de Diroban \u00e9 patrocinado pela Anzac Animal Health, LLC e distribu\u00eddo pela Zoetis, Inc.<\/p>\n<p>\u2022 A Ceva Animal Health anunciou o lan\u00e7amento da Cevac IBron, uma vacina av\u00edcola rotulada para combater as cepas do v\u00edrus da bronquite infecciosa (IBV) da Ge\u00f3rgia em aves. Cevac IBron pode ser usado em galinhas saud\u00e1veis com um dia de idade ou mais. (Farm\u00e1cia Animal)<\/p>\n<p>\u2022 A VetStem Biopharma anunciou a abertura de sua unidade de fabrica\u00e7\u00e3o de terapia celular GMP no laborat\u00f3rio de sua sede em Poway, Calif\u00f3rnia. De acordo com a empresa, \u00e9 a primeira instala\u00e7\u00e3o de terapia celular espec\u00edfica para veterin\u00e1ria nos EUA. (PRweb)<\/p>\n<p>\u2022 BuddyRest Pet Products anunciou que adquiriu a marca PetNV da Envision. Os termos financeiros n\u00e3o foram divulgados. (Neg\u00f3cio de animais de estima\u00e7\u00e3o)<\/p>\n<p>\u2022 A Maple Leaf Foods anunciou um acordo definitivo com a Brynwood Partners VI LP para adquirir a Lightlife Foods Inc., fabricante e marca l\u00edder de alimentos prot\u00e9icos refrigerados \u00e0 base de plantas nos EUA, por $140 milh\u00f5es e custos relacionados. A Lightlife relatou vendas em 2016 de aproximadamente $40 milh\u00f5es e tem uma participa\u00e7\u00e3o de mercado de 38% no mercado de prote\u00ednas vegetais refrigeradas dos EUA. (Alimentos)<\/p>\n<p>\u2022 UE O Comit\u00e9 de Medicamentos para Uso Veterin\u00e1rio (CVMP) da Ag\u00eancia Europeia de Medicamentos recomendou uma autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado para o anticorpo monoclonal Cytopoint da Zoetis para o tratamento da dermatite at\u00f3pica canina. O produto seria o primeiro anticorpo monoclonal veterin\u00e1rio (mAb) aprovado no mercado europeu. (Farm\u00e1cia Animal)<\/p>\n<p>\u2022 CHINA A Ceva Sant\u00e9 Animale e a empresa chinesa EBVAC anunciaram um acordo de joint venture para criar um novo neg\u00f3cio, Ceva EBVAC, focado no setor su\u00edno chin\u00eas. A Ceva deter\u00e1 a maioria das a\u00e7\u00f5es da nova parceria. (comunicado de imprensa da empresa)<\/p>\n<p>\u2022 \u00cdNDIA A Cipla anunciou planos de vender seu neg\u00f3cio de sa\u00fade animal, Cipla Vet, para se concentrar nos mercados humanos brasileiro e chin\u00eas. (Moneycontrol. com)<br \/>\n&nbsp; <br \/>\n***********************************<br \/>\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/p>\n<p>\u2022 EUA \u2013 LEPTOSPIROSE O Arizona est\u00e1 alertando os donos de animais de estima\u00e7\u00e3o para vacinarem seus c\u00e3es contra a leptospirose, citando um aumento cont\u00ednuo no n\u00famero de c\u00e3es diagnosticados com leptospirose. (Farm\u00e1cia Animal)<\/p>\n<p>\u2022 EUA \u2013 TERAPIA G\u00c9NICA Pesquisadores do Instituto de Medicina de C\u00e9lulas-Tronco e Medicina Regenerativa da Universidade de Washington demonstraram que a terapia gen\u00e9tica pode restaurar a for\u00e7a muscular e prolongar a vida de c\u00e3es com a doen\u00e7a gen\u00e9tica miopatia miotubular (MTM). Os c\u00e3es doentes tratados com uma \u00fanica infus\u00e3o da terapia corretiva eram indistingu\u00edveis dos animais normais um ano depois. As descobertas foram publicadas online na revista Molecular Therapy. (Alimentos)<br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>BRAKKE CONSULTING, INC.<br \/>\nENTENDENDO O MERCADO DE BOLSA<\/strong><\/p>\n<p>Quer sua empresa esteja considerando os canais OTC para novas oportunidades de neg\u00f3cios ou voc\u00ea j\u00e1 distribua nos canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade para empresas que buscam aprender mais sobre os detalhes dos canais de distribui\u00e7\u00e3o OTC. Se voc\u00ea estiver procurando insights significativos sobre os canais OTC, as tend\u00eancias encontradas neles e as oportunidades que existem, entre em contato com Joel Adamson em <a href=\"mailto:jadamson@brakkeconsulting.com\">jadamson@brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n************************************<br \/>\nPONTO DE VISTA DA BRAKKE CONSULTORIA<\/p>\n<p>Com as not\u00edcias desta semana, a maioria das empresas p\u00fablicas de sa\u00fade animal j\u00e1 reportou os resultados de 2016. \u00c9 interessante comparar os relat\u00f3rios de receitas dos fabricantes com os da distribui\u00e7\u00e3o. O crescimento da receita de distribui\u00e7\u00e3o ano ap\u00f3s ano tem sido maior do que a maioria dos fabricantes relata. Acreditamos que essa diferen\u00e7a se deve principalmente ao mix mais amplo de produtos de distribui\u00e7\u00e3o versus manufatura.<\/p>\n<p>Embora esteja demorando para atingir a comercializa\u00e7\u00e3o total, esta semana h\u00e1 dois artigos relacionados \u00e0 terapia celular e gen\u00e9tica. Ser\u00e1 que estas tecnologias chegar\u00e3o \u00e0 comercializa\u00e7\u00e3o a um custo que permitir\u00e1 a sua ampla utiliza\u00e7\u00e3o?&nbsp;<\/p>\n<p>Se voc\u00ea quiser saber mais sobre o que consideramos serem os impulsionadores de neg\u00f3cios em sa\u00fade animal para 2017 e no futuro, sugerimos que voc\u00ea se registre para nossa Vis\u00e3o Geral da Ind\u00fastria de Sa\u00fade Animal de 2017 na WVC no dia 7 de mar\u00e7o. Ainda restam algumas vagas dispon\u00edveis.<\/p>\n<p>Tenha um \u00f3timo fim de semana!!<\/p>\n<p>Ron Brakke<br \/>\n&nbsp; <br \/>\n**********************************<br \/>\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<\/p>\n<p>Para obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke Consulting, Inc.<br \/>\n12005 Ford Rd., Suite 530<br \/>\nDallas, TX 75234 EUA<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>para impress\u00e3o *********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 24 de fevereiro de 2017 Direitos autorais \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ NO NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Vis\u00e3o geral da ind\u00fastria no WVC OTC Channel not\u00edcias sobre ganhos Avivagen Bayer Ebos Group Henry Schein JM Smucker Patterson outras not\u00edcias Anzac Animal Health BuddyRest Pet Products Ceva (Cevac IBron) Ceva (EBVAC) Cipla Vet EBVAC Envision Maple Leaf Foods VetStem Biopharma Zoetis ( Diroban) Zoetis (Cytopoint) *********************************** BRAKKE CONSULTING, INC. REGISTRO DE VIS\u00c3O GERAL DA IND\u00daSTRIA 2017 PARA VIS\u00c3O GERAL NO WVC A INSCRI\u00c7\u00c3O ONLINE TERMINA SEXTA-FEIRA! A Brakke Consulting tem o prazer de anunciar a Vis\u00e3o Geral da Ind\u00fastria de 2017. A Vis\u00e3o Geral da Ind\u00fastria de Sa\u00fade Animal dos EUA de 2017 ser\u00e1 apresentada na Western Veterinary Conference em Las Vegas, Nevada: \u2022 WVC: ter\u00e7a-feira, 7 de mar\u00e7o de 2017, das 14h \u00e0s 16h, Four Seasons. Para se registrar, acesse www.BrakkeConsulting.com e role para baixo at\u00e9 a \u00e1rea \u201cnovidades\u201d da p\u00e1gina inicial. As inscri\u00e7\u00f5es online terminam na sexta-feira, 3 de mar\u00e7o; ap\u00f3s esse hor\u00e1rio, registre-se no local. www.BrakkeConsulting.com *********************************** DIVULGA\u00c7\u00d5ES DE RESULTADOS DA EMPRESA \u2022 A Bayer divulgou os resultados do ano completo de 2016. As vendas do neg\u00f3cio de Sa\u00fade Animal foram de 1,52 bilh\u00e3o de euros ($1,60 bilh\u00e3o), um aumento de 2% (+5% com ajuste de moeda e portf\u00f3lio). (website da empresa) \u2022 Henry Schein reportou os resultados financeiros do ano de 2016. As vendas de Sa\u00fade Animal foram de $3,25 bilh\u00f5es,<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/24003\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-24003","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/24003\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 24, 2017 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news Industry Overview at WVC OTC Channel &nbsp; &nbsp; earnings news Avivagen Bayer Ebos Group Henry Schein J. M. Smucker Patterson &nbsp; other news Anzac Animal Health BuddyRest Pet Products Ceva (Cevac IBron) Ceva (EBVAC) Cipla Vet EBVAC Envision Maple Leaf Foods VetStem Biopharma Zoetis (Diroban) Zoetis (Cytopoint) &nbsp; *********************************** BRAKKE CONSULTING, INC. 2017 INDUSTRY OVERVIEW REGISTRATION FOR OVERVIEW AT WVC ONLINE REGISTRATION ENDS FRIDAY! Brakke Consulting is pleased to announce the 2017 Industry Overview. The 2017 US Animal Health Industry Overview will be presented at the Western Veterinary Conference in Las Vegas, Nevada: &bull; WVC: Tuesday, March 7, 2017, 2:00 &ndash; 4:00 pm, Four Seasons. To register, go to www.BrakkeConsulting.com and scroll down to the &ldquo;what&rsquo;s new&rdquo; area of the home page.&nbsp; Online registration ends Friday, March 3; after that time please register on-site. &nbsp; www.BrakkeConsulting.com &nbsp; *********************************** COMPANY EARNINGS RELEASES &bull;&nbsp;Bayer reported the results for the full year 2016. Sales of the Animal Health business were EUR 1.52 billion ($1.60 billion), an increase of 2% (+5% currency &amp; portfolio adj.).&nbsp; (company website) &bull;&nbsp;Henry Schein reported full year 2016 financial results. Animal Health sales were $3.25 billion,View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/24003\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-24T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:15:33+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/24003\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/24003\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for February 24, 2017\",\"datePublished\":\"2017-02-24T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:15:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/24003\/\"},\"wordCount\":1149,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/24003\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/24003\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"datePublished\":\"2017-02-24T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:15:33+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/24003\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/24003\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/24003\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for February 24, 2017\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/24003\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 24, 2017 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news Industry Overview at WVC OTC Channel &nbsp; &nbsp; earnings news Avivagen Bayer Ebos Group Henry Schein J. M. Smucker Patterson &nbsp; other news Anzac Animal Health BuddyRest Pet Products Ceva (Cevac IBron) Ceva (EBVAC) Cipla Vet EBVAC Envision Maple Leaf Foods VetStem Biopharma Zoetis (Diroban) Zoetis (Cytopoint) &nbsp; *********************************** BRAKKE CONSULTING, INC. 2017 INDUSTRY OVERVIEW REGISTRATION FOR OVERVIEW AT WVC ONLINE REGISTRATION ENDS FRIDAY! Brakke Consulting is pleased to announce the 2017 Industry Overview. The 2017 US Animal Health Industry Overview will be presented at the Western Veterinary Conference in Las Vegas, Nevada: &bull; WVC: Tuesday, March 7, 2017, 2:00 &ndash; 4:00 pm, Four Seasons. To register, go to www.BrakkeConsulting.com and scroll down to the &ldquo;what&rsquo;s new&rdquo; area of the home page.&nbsp; Online registration ends Friday, March 3; after that time please register on-site. &nbsp; www.BrakkeConsulting.com &nbsp; *********************************** COMPANY EARNINGS RELEASES &bull;&nbsp;Bayer reported the results for the full year 2016. Sales of the Animal Health business were EUR 1.52 billion ($1.60 billion), an increase of 2% (+5% currency &amp; portfolio adj.).&nbsp; (company website) &bull;&nbsp;Henry Schein reported full year 2016 financial results. Animal Health sales were $3.25 billion,View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/24003\/","og_site_name":"Brakke Consulting Website","article_published_time":"2017-02-24T18:51:17+00:00","article_modified_time":"2018-04-14T07:15:33+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/24003\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/24003\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for February 24, 2017","datePublished":"2017-02-24T18:51:17+00:00","dateModified":"2018-04-14T07:15:33+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/24003\/"},"wordCount":1149,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/24003\/","url":"https:\/\/brakkeconsulting.com\/zh\/24003\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"datePublished":"2017-02-24T18:51:17+00:00","dateModified":"2018-04-14T07:15:33+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/24003\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/24003\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/24003\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for February 24, 2017"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=24003"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24003\/revisions"}],"predecessor-version":[{"id":25583,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24003\/revisions\/25583"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=24003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=24003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=24003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}